
Relmada Therapeutics, Inc. (RLMD) Q3 2022 Earnings Call Transcript
Relmada Therapeutics, Inc. (NASDAQ:RLMD) Q3 2022 Earnings Conference Call November 10, 2022 4:30 PM ET Company Participants Brian Ritchie – LifeSci Advisors Sergio Traversa – Chief Executive Officer Maged Shenouda – Chief Financial Officer Maurizio […]